| 000 | 01123 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250514074457.0 | ||
| 264 | 0 | _c20030910 | |
| 008 | 200309s 0 0 eng d | ||
| 022 | _a0362-5664 | ||
| 024 | 7 |
_a10.1097/00002826-200307000-00003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarini, Ann M | |
| 245 | 0 | 0 |
_aTransient neurologic deficits associated with carbamazepine-induced hypertension. _h[electronic resource] |
| 260 |
_bClinical neuropharmacology _c |
||
| 300 |
_a174-6 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCarbamazepine _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNervous System Diseases _xchemically induced |
| 650 | 0 | 4 |
_aNeurotoxicity Syndromes _xcomplications |
| 700 | 1 | _aChoi, John Y | |
| 700 | 1 | _aLabutta, Robert J | |
| 773 | 0 |
_tClinical neuropharmacology _gvol. 26 _gno. 4 _gp. 174-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-200307000-00003 _zAvailable from publisher's website |
| 999 |
_c12672930 _d12672930 |
||